Feed SANA
SA

Sana Biotechnology, Inc. SANA NASDAQ · Healthcare · United States

$1.85 -1.60% -$0.03

Market cap
$554.3M
Enterprise value
$567.1M
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/FCF
-
EV/EBITDA
-
ROIC
-46.4%
Gross margin
-
Net margin
-
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
2.30
Free float
63.8%

Sector

Healthcare

Industry

Biotechnology

CEO

Steven D. Harr

Employees

142

Headquarters

Seattle

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

  • What to watch: It passes only 1 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

  • What to watch: The price moves much more than the market (beta 2.30).

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy